Descrizione del progetto
Una soluzione sicura per i pazienti infetti
I focolai di malattie infettive sono responsabili di migliaia di morti in tutto il mondo. I modelli di viaggio della nostra società moderna aumentano ulteriormente i rischi per la salute, l’economia e la sicurezza associati a tali epidemie. Unità di isolamento specializzate sono state sviluppate da EpiGuard, che comprende un gruppo di medici che hanno lavorato per contenere l’infezione da Ebola. Dopo tre anni di ricerca è stata ideata la soluzione EpiShuttle: un’unità di isolamento specializzata individuale, rigida (in policarbonato) e riutilizzabile. Nell’ambito dell’iniziativa EpiShuttle 2.0 EpiGuard mira a combinare la moderna tecnologia di disinfezione a vapore con EpiShuttle per rendere la rispettiva tecnologia economica e applicabile al più ampio mercato globale per un valore di miliardi di euro.
Obiettivo
The Problem: An increasing number of outbreaks with infectious diseases are seen globally. Ebola has claimed at least 77 lives in DRC (Congo) so far this year and over 11 thousand people West Africa in 2014. Other recent outbreaks are the SARS-epidemic, the MERS-cases in Asia, multi-resistant tuberculosis and the pulmonary Plague epidemic in Madagascar, Zika virus in Brazil, etc. Each of these events demonstrated the large health, economic and security risks associated with infectious disease outbreaks. The travelling patterns of our modern society increases the risk of a global “catastrophe”. To handle outbreaks, the CDC highly recommends the use of specialized isolation units (SIU) to isolate and transport the infected patients. The Solution: EpiGuard was founded in 2015 by a group of medical doctors that faced the challenge of managing Ebola patients on the field. After 3 years and ~5 million EUR of capital and labour investment, the company has recently launched into EU market the EpiShuttle solution – the world-first hard-top (polycarbonate), reusable SIU, representing a leap forward against the state of the art. The EpiShuttle is a one-person SIU, providing complete protection from contagious diseases, without compromising advanced treatment and care to the patient. The Opportunity: Partnering with a world-class design and engineering team, EpiGuard wants to position EpiShuttle as the gold standard for SIUs in the emergency workflow. EpiShuttle targets a 12 Bill. EUR market opportunity worldwide. Although the response from medical professionals has been positive, to fully exploit the market potential, there is a need for combining modern gas disinfection technology with EpiShuttle to allow re-use in a cost effective manner. Further, to expand the market outside Europe, regulatory clearance in USA and China plus a larger size unit for the USA market are needed.
Campo scientifico
Parole chiave
Programma(i)
Argomento(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-SMEInst-2018-2020-2
Meccanismo di finanziamento
SME-2 - SME instrument phase 2Coordinatore
1634 Gamle Fredrikstad
Norvegia
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.